Episode 69: The future of AbbVieGan, the dogma of amyloid, & some questionable biotech marketing

The Readout Loud - A podcast by STAT - Thursdays

Categories:

Can Botox make Big Pharma attractive? What qualifies as a "cabal"? And will the CRISPR patent fight outlive us all?